Gordian Surgical Receives Investment from Chinese VC Virtus Inspire Ventures

Ed. note: News about the Gordian raise appeared on more than 170 websites, including Globes, GeekTime, No Camels, and Mass Device.

Tel Aviv, Israel, October 20, 2015 – Gordian Surgical, a portfolio company of Trendlines Medical, announced the completion of a raise nearing $1 million, including an investment from Virtus Inspire Ventures, a Chinese venture capital firm. Participants in the round are leading U.S. laparoscopic surgeons, including Prof. Barry Salky, and other investors.

Gordian Surgical trocar

Gordian Surgical’s trocar with built-in closure device

Gordian intends to use the funds to complete American (FDA) and European (CE) regulatory processes, start first-in-man (clinical) trials, and prepare for market penetration.

Gordian has developed an innovative trocar that offers surgeons a simple, economical solution for opening and suturing (closing) internal incisions made during laparoscopic surgery. The “two-in-one” trocar inserts sutures into the tissue surrounding the incision at the beginning of the procedure and anchors them to stay in place throughout the operation. The built-in closure mechanism enables surgeons to easily close the sutures when the trocar is removed at the end of the procedure.

Minimally invasive, laparoscopic procedures involve making a number of small incisions in the abdominal cavity for placing cameras and surgical tools. Despite the more than 10 million laparoscopic surgeries performed worldwide, the challenge of closing the abdominal incisions remains time-consuming, requires expertise, and poses risks of post-operation complications such as hernias.

Zvi Pe’er, CEO of Gordian Surgical, remarks: “I am extremely pleased by the growing level of interest in our company and technology. This investment by a VC and senior surgeons is evidence of the confidence in our team and in the market potential of our products.”

Eran Feldhay, CEO of Trendlines Medical, adds: “We are very proud of Gordian’s progress as a company that is developing a simple, cost-saving trocar to reduce the risks and complications of laparoscopic procedures and has attracted global interest from investors and industry leaders.”

Leave a Reply

  • Welcome to Trendlines

    We invest in, incubate, and support early-stage, high-promise medical and agricultural technology companies in Israel, a global leader in start-up ingenuity. Read More >

  • Categories

  • Subscribe to Our Newsletter

  • Stay in Touch

    icon-facebook Like us on Facebook

    icon-Twitter Follow us on Twitter

    icon-Linkedin Connect with us on Linkedin

    YouTube-color See us on YouTube

    flipboard  Read us on Flipboard

    google+_icon Join us on Google+